Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...

Molecular Switches as Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application Market Research Report 2025 with Top 20 Drugs Sales Targeting Molecular Switches 2022-2024 ...

PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced the publication of a ...

PhoreMost has published new data validating its GlueSEEKER platform, a high-throughput technology designed to accelerate ...

Cite this: Polymer–Drug Conjugates for Novel Molecular Targets - Medscape - Aug 01, 2010. Abstract and Introduction Polymer–Drug Conjugates for Emerging Targets in Cancer Therapy ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

An international team of researchers led by Konstanz biologists has identified a molecular mechanism that regulates the activity of N-myristoyltransferases. This enzyme plays a role in biological ...

Molecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development Provided by GlobeNewswire Jun 4, 2025, 8:00:00 AM ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen receptor axis have significantly delayed disease progression. However, drug ...